comparemela.com

Latest Breaking News On - Innovationquarter capital - Page 1 : comparemela.com

Qualinx s Series A Financing for All-Digital GNSS IoT Wireless Technology Hits $20 Million

Qualinx, a pioneer in ultra-low power wireless tracking and connectivity semiconductors, has announced that its Series A financing has reached $20 million.

Zuid hollandMarcus preijdeSteve dickensAmir reza ahmadi mehrDelft university of technologyNetherlands enterprise agencyFuturum groupDutch ministry of economic affairsInnovationquarter capitalWaterman venturesInnovation creditTom trillDigital radio frequencyGlobal navigation satellite systemsPractice leaderDelft university

New Electronics - Qualinx s Series A funding for GNSS IoT wireless technology hits $20mn

Qualinx, a company that’s developing ultra-low power wireless tracking and connectivity semiconductors, has announced that its Series A financing has reached $20 million.

Zuid hollandDelft university of technologyDelft enterprisesNetherlands enterprise agencyInnovationquarter capitalWaterman venturesInnovation creditDelft universityGlobal navigation satellite systemsTom trillDigital radio frequency

Qualinx raises $20m Series A

Qualinx, the Dutch wireless tracking specialist, has completed a $20 million Series A. $10.2 million has been added to the $8.8 million investment

Zuid hollandDelft enterprisesNetherlands enterprise agencyDelft university of technologyInnovationquarter capitalWaterman venturesInnovation creditDelft universityTom trillDigital radio frequencyGlobal navigation satellite systems

Qualinx raises $10 2m to speed up GNSS IoT radio SoC launch

Dutch fabless semiconductor company Qualinx has secured a USD 10.2 million Series A extension round to bring its lifetime funding to USD 20 million.

Netherlands enterprise agencyInnovation creditTom trillInnovationquarter capitalWaterman ventures

Dutch-based Synerkine Pharma scores €5 3M to create innovative pain solutions

Synerkine Pharma, a biopharmaceutical company based in Leiden has successfully secured €5.3M in an extension of its Series A financing.

City ofUnited kingdomSynerkine pharmaHans preustingUniversity medical center utrechtNetherlands enterprise agencyUtrecht health seed fundInnovationquarter capitalNetherlands enterpriseThuja capitalChief executive officerUniversity medical center

vimarsana © 2020. All Rights Reserved.